) Our objectives are to build a sustainable bioprospecting program in Panama, to e n hance conservation, and to discover new products for medicine and agriculture. Panama has more forest cover than any other Central American country, and is considered a threatened diversity hotspot. Its unique p o sition as a biological corridor joining the northern and southern hemispheres has implications for both regional and international conservation strategies. To promote conservation and sustainable bioprospecting in Panama, we are stressing technology transfer and effective drug discovery. First, we will use ecological research to target collections towards species and tissues that have a high biological activity. We will also extract fresh samples, minimizing the loss of active compounds. Second, we are placing a large emphasis on training and technology transfer to Panama. We are establishing bioassay with Human Immunodeficiency Virus (HIV) and cancer at the University of Panama and with tropical diseases at Gorgas Memorial Institute in Panama City. Active compounds will purified at the University of Panama. In addition, protein extracts will be tested for activity against whitefly, a crop pest that could become one of the major pests worldwide. Both organic and protein extracts will be sent to Monsanto, our industrial collaborator. Monsanto has committed to providing strong technical support for the pharmaceutical and agricultural investigations in Panama, especially with the identification of active compounds, thus providing a substantial component of capacity building. This emphasis on training and technology transfer creates immediate benefits to Panama and helps establish the scientific infrastructure necessary to continue bioprospecting after the termination of the grant. In addition we will assist the Kuna and Naso Indians of Panama to make a permanent record of their ethnobotanical knowledge and to increase their involvement in conservation and land management planning.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01TW001021-01
Application #
2722193
Study Section
Special Emphasis Panel (ZCA1-RLB-3 (M1))
Project Start
1998-09-30
Project End
2003-09-29
Budget Start
1998-09-30
Budget End
1999-09-29
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Smithsonian Institution
Department
Type
DUNS #
City
Arlington
State
DC
Country
United States
Zip Code
Gutierrez, Marcelino; Capson, Todd L; Guzman, Hector M et al. (2006) Antiplasmodial metabolites isolated from the marine octocoral Muricea austera. J Nat Prod 69:1379-83
Hussein, Ahmed A; Barberena, Icela; Correa, Mireya et al. (2005) Cytotoxic flavonol glycosides from Triplaris cumingiana. J Nat Prod 68:231-3
Gutierrez, Marcelino; Capson, Todd L; Guzman, Hector M et al. (2005) Leptolide, a new furanocembranolide diterpene from Leptogorgia alba. J Nat Prod 68:614-6
Garzon, Sandra P; Rodriguez, Abimael D; Sanchez, Juan A et al. (2005) Sesquiterpenoid metabolites with antiplasmodial activity from a Caribbean gorgonian coral, Eunicea sp. J Nat Prod 68:1354-9
Hussein, Ahmed A; Barberena, Icela; Capson, Todd L et al. (2004) New cytotoxic naphthopyrane derivatives from Adenaria floribunda. J Nat Prod 67:451-3
Corbett, Yolanda; Herrera, Liuris; Gonzalez, Jose et al. (2004) A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity. Am J Trop Med Hyg 70:119-24
Rodriguez, Ileana I; Shi, Yan-Ping; Garcia, Oscar J et al. (2004) New pseudopterosin and seco-pseudopterosin diterpene glycosides from two Colombian isolates of Pseudopterogorgia elisabethae and their diverse biological activities. J Nat Prod 67:1672-80
Torres-Mendoza, Daniel; Urena Gonzalez, Luis David; Ortega-Barria, Eduardo et al. (2004) Novel cassane and cleistanthane diterpenes from Myrospermum frutescens: absolute stereochemistry of the cassane diterpene series. J Nat Prod 67:1711-5
Marrero, Jeffrey; Rodriguez, Abimael D; Baran, Peter et al. (2004) Bielschowskysin, a gorgonian-derived biologically active diterpene with an unprecedented carbon skeleton. Org Lett 6:1661-4
Williams, Cornelly; Espinosa, Omar A; Montenegro, Hector et al. (2003) Hydrosoluble formazan XTT: its application to natural products drug discovery for Leishmania. J Microbiol Methods 55:813-6

Showing the most recent 10 out of 13 publications